{
    "2019-04-16": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran",
                "features": {
                    "keywords": [
                        "Phase III",
                        "ILLUMINATE-B",
                        "Lumasiran"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales",
                "features": {
                    "keywords": [
                        "Radius Health",
                        "Tymlos",
                        "Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Allergan Falls as Supreme Court Dismisses Restasis Litigation",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Supreme Court",
                        "Restasis",
                        "Litigation"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "BLA",
                        "Ophthalmology",
                        "FDA"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Marijuana ETF Down 9% in Past Month: Time to Enter the Space?",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "ETF",
                        "Down"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financials",
                        "ETFs"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",
                "features": {
                    "keywords": [
                        "Biotech",
                        "J&J",
                        "Earnings",
                        "FDA",
                        "Medicinova",
                        "Proteon"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}